As part of a clinical study, the Early Clinical Trial Unit (ECTU) at NCT/UCC Dresden tested the cancer immunotherapy IMA401 for the first time in patients with advanced solid tumors. IMA401 is a so-called bispecific T-cell ...
May 31, 2026
0
11
A gentler treatment for children whose leukemia has come back could boost survival and quality of life, a study led by a UCL academic has found. The new regime significantly reduces the need for intensive chemotherapy and ...
Apr 30, 2026
0
11
Mayo Clinic researchers have developed a blood-based method that may help detect germ cell tumors, the most common type of testicular cancer, including cases that do not show up on standard blood tests, according to a study ...
May 3, 2026
0
11
People who vape regularly show altered activity in 3,124 genes across the genome compared with people who do not smoke or vape. While some of those changes (28.8%) relate to how often or how much people vape, a much greater ...
Jun 1, 2026
0
11
Researchers at the University of Illinois Chicago have developed an anti-cancer therapy inspired by bacteria found in cancer tumors. When tested in combination with radiation in animal models of prostate cancer, it was highly ...
Apr 29, 2026
0
11
The protein p53 is often called the guardian of the genome for its central role in preventing cancer. Yet paradoxically, it is also one of the most frequently mutated and dysfunctional proteins in human tumors.
May 20, 2026
2
11
The combination of a vaccine and a drug, which both harness the immune system to attack cancer cells, has proven successful in cutting the risk of skin cancer recurrence and death by 49%, a new study shows. This reduction ...
Jun 1, 2026
0
11
Scientists at Houston Methodist have developed an artificial intelligence platform that can decode how cells communicate inside the human body, opening a window into conditions such as Alzheimer's disease, cancer, and potentially ...
May 14, 2026
0
10
Researchers at the Johns Hopkins Kimmel Cancer Center and the Telomere Clinic at Johns Hopkins have identified a genetic syndrome in which unusually long telomeres—the protective caps at the ends of chromosomes—allow immune ...
May 7, 2026
0
10
Scientists at the UCLA Health Jonsson Comprehensive Cancer Center have developed a new cytokine-armored CAR-T cell therapy that helps the immune system better attack aggressive brain tumors in mice while reducing dangerous ...
May 20, 2026
0
10
